{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:21:48Z","timestamp":1787840508860,"version":"build-2784847793"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>Cysteine-rich 61 (Cyr61) may enhance angiogenesis and inflammation in diabetic retinopathy (DR). Cyclooxygenase-2 (COX-2) is an immediate-early gene product of inflammation and it also plays an important role in developing DR. We aim to investigate the effects of Cyr61 on COX-2 expression in chorioretinal vascular endothelial (RF\/6A) cells and to study the possible signal transduction pathway and the transcriptional mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>The effects of Cyr61 on COX-2 expression were evaluated via determining the mRNA, protein, and prostaglandin (PG) E2 levels of RF\/6A cells. To examine the pathway in this process, RF\/6A cells were pretreated with integrin \u03b1\u03bd\u03b23-blocking antibodies, a FAK inhibitor (PF573228), a PI3K inhibitor (LY294002), and an Akt inhibitor (A6730), respectively. Electrophoretic mobility shift assays (EMSAs) and luciferase reporter assays were applied to assess if NF-\u03baB was involved in this response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Cyr61 stimulated the expression of COX-2 at the mRNA, protein, and PGE2 levels in a dose-dependent and time-dependent manner. Both COX-2 and PGE\n                      <jats:sub>2<\/jats:sub>\n                      levels were attenuated during the response to Cyr61 stimulation by pretreatment with integrin \u03b1\u03bd\u03b23-blocking antibodies, PF573228, LY294002, and A6730 respectively. EMSA revealed that all of the aforementioned inhibitors suppressed NF-\u03baB activation. Luciferase reporter assays further indicated that the mutation of the NF-\u03baB-binding element in the COX-2 gene promoter reduced its gene expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Induction of COX-2 by Cyr61 is mediated through the activation of the integrin \u03b1\u03bd\u03b23, FAK, PI3K\/Akt, and NF-\u03baB pathways in RF\/6A cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-24-00086","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:01:04Z","timestamp":1739167264000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cysteine-rich 61 mediates inflammation by the NF-\u03baB\/cyclooxygenase-2 pathway in RF\/6A cells"],"prefix":"10.4103","volume":"15","author":[{"given":"Po-Ting","family":"Yeh","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jang","family":"You","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Keelung Hospital of the Ministry of Health and Welfare, the Executive Yuan, Keelung, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.eye.6701476","article-title":"Epidemiology of diabetic retinopathy and macular oedema:A systematic review","volume":"18","author":"Williams","year":"2004","journal-title":"Eye (Lond)"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dsx.2014.09.011","article-title":"Diabetic retinopathy \u2013Biomolecules and multiple pathophysiology","volume":"9","author":"Ahsan","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"R4-20250618","first-page":"849","article-title":"Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey","volume":"43","author":"Witmer","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"3420187","DOI":"10.1155\/2018\/3420187","article-title":"The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy","volume":"2018","author":"Wu","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"935301","DOI":"10.1155\/2013\/935301","article-title":"Vitreous mediators in retinal hypoxic diseases","volume":"2013","author":"dell'Omo","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"582060","DOI":"10.1155\/2015\/582060","article-title":"Diabetic retinopathy:Vascular and inflammatory disease","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"R8-20250618","first-page":"1109","article-title":"ERK1\/2\/COX-2\/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes","volume":"20","author":"Li","year":"2014","journal-title":"Mol Vis"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cca.2018.06.028","article-title":"Tumor necrosis factor-\u03b1 and diabetic retinopathy:Review and meta-analysis","volume":"485","author":"Yao","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.eye.6702138","article-title":"Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy","volume":"20","author":"Demircan","year":"2006","journal-title":"Eye (Lond)"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1388-1981(99)00147-X","article-title":"The cyclooxygenase isoforms:Structural insights into the conversion of arachidonic acid to prostaglandins","volume":"1441","author":"Garavito","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/02713688409000813","article-title":"Arachidonic acid metabolism by retinas of rats with streptozotocin-induced diabetes","volume":"3","author":"Naveh-Floman","year":"1984","journal-title":"Curr Eye Res"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1076\/ceyr.18.2.79.5386","article-title":"Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature","volume":"18","author":"Johnson","year":"1999","journal-title":"Curr Eye Res"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.12-10410","article-title":"Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines","volume":"53","author":"Schoenberger","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.2174\/1381612043383142","article-title":"Vasoactive factors and diabetic retinopathy:Vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide","volume":"10","author":"Wilkinson-Berka","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2004.07.046","article-title":"Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas","volume":"498","author":"Ayalasomayajula","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.1999.tb08726.x","article-title":"COX-2 inhibitors. A new class of antiangiogenic agents","volume":"889","author":"Masferrer","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0192623308329474","article-title":"Pathophysiology of cyclooxygenase inhibition in animal models","volume":"37","author":"Radi","year":"2009","journal-title":"Toxicol Pathol"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1210\/endo.142.6.8186","article-title":"Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation:Regulation by 17beta-estradiol and overexpression in human breast cancer","volume":"142","author":"Sampath","year":"2001","journal-title":"Endocrinology"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"47709","DOI":"10.1074\/jbc.M107878200","article-title":"Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer","volume":"276","author":"Tong","year":"2001","journal-title":"J Biol Chem"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo.143.4.8731","article-title":"The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha (6) beta (1) and cell surface heparan sulfate proteoglycans","volume":"143","author":"Grzeszkiewicz","year":"2002","journal-title":"Endocrinology"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1167\/iovs.08-2603","article-title":"Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy","volume":"50","author":"You","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IAE.0b013e318219e4ad","article-title":"Elevation of angiogenic factor cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy","volume":"32","author":"You","year":"2012","journal-title":"Retina"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.exer.2010.10.006","article-title":"Regulation of Cyr61\/CCN1 expression by hypoxia through cooperation of c-Jun\/AP-1 and HIF-1\u03b1 in retinal vascular endothelial cells","volume":"91","author":"You","year":"2010","journal-title":"Exp Eye Res"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cellsig.2013.08.026","article-title":"Cyr61 induces the expression of monocyte chemoattractant protein-1 via the integrin \u03b1\u03bd\u03b23, FAK, PI3K\/Akt, and NF-\u03baB pathways in retinal vascular endothelial cells","volume":"26","author":"You","year":"2014","journal-title":"Cell Signal"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1210\/en.2012-1993","article-title":"Cyclooxygenase-2 regulated by the nuclear factor-\u03baB pathway plays an important role in endometrial breakdown in a female mouse menstrual-like model","volume":"154","author":"Xu","year":"2013","journal-title":"Endocrinology"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pep.2005.03.031","article-title":"Expression, purification, and functional testing of recombinant CYR61\/CCN1","volume":"42","author":"Sch\u00fctze","year":"2005","journal-title":"Protein Expr Purif"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.1998.9939","article-title":"Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells","volume":"254","author":"Inoue","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"FASEB J"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy","volume":"108","author":"Sennlaub","year":"2003","journal-title":"Circulation"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"95103","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/S0962935196000452","article-title":"Cyclooxygenase-2 and its regulation in inflammation","volume":"5","author":"Bakhle","year":"1996","journal-title":"Mediators Inflamm"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2004.04.008","article-title":"Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization","volume":"79","author":"Castro","year":"2004","journal-title":"Exp Eye Res"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1167\/iovs.02-0392","article-title":"COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity","volume":"44","author":"Wilkinson-Berka","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1167\/iovs.10-6319","article-title":"Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice","volume":"52","author":"Rezaei","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/IAE.0b013e3181c59698","article-title":"Cyclo-oxygenase-2 expression in human idiopathic epiretinal membrane","volume":"30","author":"Kase","year":"2010","journal-title":"Retina"},{"key":"R38-20250618","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1074\/jbc.273.5.3090","article-title":"Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3","volume":"273","author":"Kireeva","year":"1998","journal-title":"J Biol Chem"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1128\/MCB.16.4.1326","article-title":"Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion","volume":"16","author":"Kireeva","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R40-20250618","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1074\/jbc.M113.533042","article-title":"Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration","volume":"289","author":"Wu","year":"2014","journal-title":"J Biol Chem"},{"key":"R41-20250618","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1158\/1078-0432.CCR-04-2639","article-title":"Cyr61 induces gastric cancer cell motility\/invasion via activation of the integrin\/nuclear factor-kappaB\/cyclooxygenase-2 signaling pathway","volume":"11","author":"Lin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R42-20250618","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/13543776.2013.818133","article-title":"Integrin modulators:A patent review","volume":"23","author":"Kapp","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"R43-20250618","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.154.7.3266","article-title":"Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains","volume":"154","author":"Fan","year":"1995","journal-title":"J Immunol"},{"key":"R44-20250618","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s000180050183","article-title":"Leukocyte integrins and inflammation","volume":"54","author":"Gahmberg","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"R45-20250618","doi-asserted-by":"crossref","first-page":"44166","DOI":"10.1074\/jbc.M406813200","article-title":"Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells","volume":"279","author":"Chen","year":"2004","journal-title":"J Biol Chem"},{"key":"R46-20250618","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V99.12.4457","article-title":"Identification of integrin alpha (M) beta (2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2):Immediate-early gene products expressed in atherosclerotic lesions","volume":"99","author":"Schober","year":"2002","journal-title":"Blood"},{"key":"R47-20250618","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2005-06-2509","article-title":"Integrin alphaDbeta2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties","volume":"107","author":"Yakubenko","year":"2006","journal-title":"Blood"},{"key":"R48-20250618","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00281-014-0420-1","article-title":"Matricellular protein CCN1\/CYR61:A new player in inflammation and leukocyte trafficking","volume":"36","author":"Emre","year":"2014","journal-title":"Semin Immunopathol"},{"key":"R49-20250618","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.yexcr.2008.05.016","article-title":"The role of integrin alpha D beta2 (CD11d\/CD18) in monocyte\/macrophage migration","volume":"314","author":"Yakubenko","year":"2008","journal-title":"Exp Cell Res"},{"key":"R50-20250618","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1473-0502(03)00044-2","article-title":"Platelets in hemostasis and thrombosis:Role of integrins and their ligands","volume":"28","author":"Ni","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"R51-20250618","doi-asserted-by":"crossref","first-page":"33801","DOI":"10.1074\/jbc.M305862200","article-title":"Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61)","volume":"278","author":"Leu","year":"2003","journal-title":"J Biol Chem"},{"key":"R52-20250618","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1242\/jcs.02565","article-title":"Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397","volume":"118","author":"Hamadi","year":"2005","journal-title":"J Cell Sci"},{"key":"R53-20250618","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.21194","article-title":"Functional properties and intracellular signaling of CCN1\/Cyr61","volume":"100","author":"Chen","year":"2007","journal-title":"J Cell Biochem"},{"key":"R54-20250618","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.intimp.2011.02.008","article-title":"CTGF inhibits cell motility and COX-2 expression in oral cancer cells","volume":"11","author":"Chuang","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"R55-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10059-013-0139-1","article-title":"Nuclear FAK:A new mode of gene regulation from cellular adhesions","volume":"36","author":"Lim","year":"2013","journal-title":"Mol Cells"},{"key":"R56-20250618","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/or.2015.4103","article-title":"Binding of MMP-9-degraded fibronectin to \u03b26 integrin promotes invasion via the FAK-Src-related Erk1\/2 and PI3K\/Akt\/Smad-1\/5\/8 pathways in breast cancer","volume":"34","author":"Li","year":"2015","journal-title":"Oncol Rep"},{"key":"R57-20250618","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1096\/fj.06-6545com","article-title":"FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K\/Akt pathway","volume":"21","author":"Thamilselvan","year":"2007","journal-title":"FASEB J"},{"key":"R58-20250618","doi-asserted-by":"crossref","first-page":"C1339","DOI":"10.1152\/ajpcell.00144.2006","article-title":"Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways","volume":"292","author":"Huang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R59-20250618","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R60-20250618","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00024382-200208000-00001","article-title":"NF-kappaB activation and inhibition:A review","volume":"18","author":"Sun","year":"2002","journal-title":"Shock"},{"key":"R61-20250618","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1167\/iovs.18-25215","article-title":"RF\/6A Chorioretinal cells do not display key endothelial phenotypes","volume":"59","author":"Makin","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:10Z","timestamp":1787837050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00086","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"2024-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}